Abalos Therapeutics
Abalos Therapeutics is an Essen, Germany-based developer of novel immuno-virotherapies against cancer.
Essen, Germanyabalos-tx.com ↗
Total raised
€43M
€43,000,000
Funding rounds
1
Investors
8
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-12 | Series A | €43M | Boehringer Ingelheim,Coparion,Gründerfonds Ruhr,High-Tech Gründerfonds (HTGF),Hx Bio Ventures,NRW.BANK+2 more | View deal → |
Investors
8Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software